North Macedonia-Skopje: Diagnostic agents
Get tender notifications and more sign up now and never miss an opportunity again. Already a member? log in to your account.
| Title | North Macedonia-Skopje: Diagnostic agents |
| OJEU (High Value) | 325000-2020 |
| Type | Invitation to tender |
| Date Published | 2020-07-10 |
| Deadline | 2020-08-06 10:00:00 |
| Nature Of Contract | Supply contract |
| Awarding Authority | |
| Procedure | Open procedure |
| Description : |
|
I.1) Name and addresses: NUTS code: 00 Communication I.3) Procurement documents (URL):https://www.e-nabavki.gov.mk/ Additional Information I.3.4) Additional information can be obtained from: I.3.6)Tenders or requests to participate must be submitted electronically via: https://www.e-nabavki.gov.mk/ I.4) Type of the contracting authority: BODY PUBLIC I.5.1) Main Activity: EDUCATION Tests for Serology Diagnosis of Infections, Identification of Microorganisms II.1.4) Short description Tests for serology diagnosis of infections, identification of microorganisms. II.1.6) This contract is divided into lots: yes Echinococcosis Antigen for Indirect Haemagglutinin Testing, for Serum Antibody Testing, with Positive and Negative Control Included II.2.1) Lot No: 1 NUTS code: 00 II.1.4) Short description Echinococcosis antigen for indirect haemagglutinin testing, for serum antibody testing, with positive and negative control included. II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Agglutination test for Streptococcus gr antigens. ABCDFG, isolated in pure culture; with positive control II.2.1) Lot No: 2 NUTS code: 00 II.1.4) Short description Agglutination test for Streptococcus gr antigens. ABCDFG, isolated in pure culture; with positive control II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Agglutination test for Cryptococcus antigens in human specimens, serum, and liquor, with positive control included II.2.1) Lot No: 3 NUTS code: 00 II.1.4) Short description Agglutination test for Cryptococcus antigens in human specimens, serum, and liquor, with positive control included II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Agglutination test to prove MRSA (methicillin-resistant Staphylococcus aureus) isolated in pure culture with positive control II.2.1) Lot No: 4 NUTS code: 00 II.1.4) Short description Agglutination test to prove MRSA (methicillin-resistant Staphylococcus aureus) isolated in pure culture with positive control II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Agglutination test for proving antigens of 6 most common causes of meningitis, for direct proof in liquor, with included positive and negative control II.2.1) Lot No: 5 NUTS code: 00 II.1.4) Short description Agglutination test for proving antigens of 6 most common causes of meningitis, for direct proof in liquor, with included positive and negative control II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Haemophilus influenzae group antigen-tested agglutination test b isolated in pure culture, with positive control II.2.1) Lot No: 6 NUTS code: 00 II.1.4) Short description Haemophilus influenzae group antigen-tested agglutination test b isolated in pure culture, with positive control II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Latex agglutination test for detection of Cl difficile, with included positive control, with included cards and agglutination sticks, with minimum sensitivity 95 % and with minimum specificity 95 % II.2.1) Lot No: 7 NUTS code: 00 II.1.4) Short description Latex agglutination test for detection of Cl difficile, with included positive control, with included cards and agglutination sticks, with minimum sensitivity 95 % and with minimum specificity 95 % II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA test for detection of Candida manganese antigen in human specimens: microtiter plate with 96 wells coated with anti-mannan monoclonal antibodies EBCA-1, wash buffer (buffer solution, concentrat II.2.1) Lot No: 8 NUTS code: 00 II.1.4) Short description ELISA test for detection of Candida manganese antigen in human specimens: microtiter plate with 96 wells coated with anti-mannan monoclonal antibodies EBCA-1, wash buffer (buffer solution, concentrated) min. 70 ml, Calibrator 0 - Tris NaCl Trehalose Buffer, min. 2 ml, Calibrator 62.5 - Tris NaCl Trehalose Buffer, min. 2 ml, calibrator 125 -Tris NaCl tracheal buffer, min. 2 ml, calibrator 250 - Tris NaCl Trehalose Buffer, min. 2 ml, calibrator 500 - Tris NaCl Trehalose Buffer, min. 2 ml, conjugate anti-mannan monoclonal antibody marked with peroxidase min. 17 ml, positive control (serum containing Candida manganese antigen) min. 1.5 mL, negative control (human serum containing no Candida manganese antigen) min 1.5 mL, TMB substrate (chromogen -3,3 ’, 5,5’-tetramethylbenzidine) min. 28 ml, stop reagent min. 28 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA test for the detection of Aspergillus galactomannan antigen in human specimens: a microtiter plate with 96 wells coated with anti-galactomanone monoclonal antibodies, buffer wash (buffer solutio II.2.1) Lot No: 9 NUTS code: 00 II.1.4) Short description ELISA test for the detection of Aspergillus galactomannan antigen in human specimens: a microtiter plate with 96 wells coated with anti-galactomanone monoclonal antibodies, buffer wash (buffer solution, concentrated) min. 70 ml, conjugate anti-galactomannan monoclonal antibody marked with peroxidase min. 8 ml, positive control (serum containing Aspergillus galactomannan antigen) min. 1.7 mL, negative control (human serum containing no Aspergillus galactomannan antigen) min 1.7 mL, TMB substrate (chromogen-3,3 ’, 5,5’-tetramethylbenzidine) min. 28 ml, stop reagent min. 28 ml. II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA test for proof of Legionella antigen in urine (double antigen ELISA sandwich), to contain a minimum of microtracheal flux divided into strips with a maximum of 96 wells coated with rabbit-speci II.2.1) Lot No: 10 NUTS code: 00 II.1.4) Short description ELISA test for proof of Legionella antigen in urine (double antigen ELISA sandwich), to contain a minimum of microtracheal flux divided into strips with a maximum of 96 wells coated with rabbit-specific ant-legionella antibodies, enzyme enzyme estrus substituted with enzyme; buffers, stop solution; positive, negative control II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA test for detection of Entamoeba antigen from faeces: microtiter plate with a maximum of 96 wells (divisible into strips) coated with specific antibodies to the antigen of Entamoeba histolytica II.2.1) Lot No: 11 NUTS code: 00 II.1.4) Short description ELISA test for detection of Entamoeba antigen from faeces: microtiter plate with a maximum of 96 wells (divisible into strips) coated with specific antibodies to the antigen of Entamoeba histolytica and Entamoeba dispar, buffer 100 ml for dilution, dilution of the sample (buffer) washing (buffer solution, concentrated) min 100 ml, positive control (inactivated antigen of Entamoeba) min 2 ml, negative control (buffer) min 2 ml, conjugate 1 (antibodies to entamoeba conjugated with biotin, in stabilized protein solution) min. 11 ml, conjugate 2 (Streptavidin poly-peroxidaza conjugate in a stabilized protein solution) min. 11 ml, substrate (chromogen, tetra-methyl-benzidine and peroxide) min. 13 ml, stop reagent min. 8 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA test for detection of Taenia solium IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divided into strips), sample dilution buffer (puffed solution) min 60 ml, washin II.2.1) Lot No: 12 NUTS code: 00 II.1.4) Short description ELISA test for detection of Taenia solium IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divided into strips), sample dilution buffer (puffed solution) min 60 ml, washing buffer (buffer solution, concentrated) 25 ml, positive control (serum with antibodies specific to Taenia solium) min 1 ml, negative control (human serum without antibodies to Taenia solium) min 2 ml, conjugate (buffer with Protein A conjugated with peroxidase) min. 11 ml, TMB substrate (chromogen, tetra-methyl-benzidine) min. 11 ml, stop reagent min. 11 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA test for detection of Ascaris IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divisible into strips), sample dilution buffer (buffer solution) min 60 ml, washing buf II.2.1) Lot No: 13 NUTS code: 00 II.1.4) Short description ELISA test for detection of Ascaris IgG from serum and / or plasma: microtiter plate with a maximum of 96 wells (divisible into strips), sample dilution buffer (buffer solution) min 60 ml, washing buffer (buffer solution, concentrated) min ml, positive control (serum with antibodies specific to Ascaris) min 1 ml, negative control (human serum without antibodies to Ascaris) min 2 ml, conjugate (buffer with Protein A conjugated with peroxidase) min. 11 ml, TMB substrate (chromogen, tetra-methyl-benzidine) min. 11 ml, stop reagent min. 11 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA antigen detection test on Cryptosporidium parvum and Cryptosporidium hominis from feces: microtiter plate with a maximum of 96 wells (divided into strips) coated with specific antibodies II.2.1) Lot No: 14 NUTS code: 00 II.1.4) Short description ELISA antigen detection test on Cryptosporidium parvum and Cryptosporidium hominis from feces: microtiter plate with a maximum of 96 wells (divided into strips) coated with specific antibodies to the antigen of the Cryptosporidium buffer solution 100mmin. ml, wash buffer (buffer solution, concentrated, thimerosal) min 100 ml, positive control (inactivated Cryptosporidium antigen) min 2 ml, negative control (buffer) min 2 ml, conjugate 1 (antibodies to specific CGs of Cryptosporidium AG biotin, in a stabilized protein solution) min. 11 ml, conjugate 2 (Streptavidin poly-peroxidaza conjugate in a stabilized protein solution) min. 11 ml, substrate (chromogen, tetra-methyl-benzidine and peroxide) min. 13 ml, stop reagent min. 8 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no ELISA IgG Detection Test Specific to E. histolytica (Amebiasis) II.2.1) Lot No: 15 NUTS code: 00 II.1.4) Short description ELISA IgG Detection Test Specific to E. histolytica (Amebiasis) II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Diagnostic test for quantitative determination of (1> 3) -beta-D-GLUCAN in serum or plasma by kinetic turbidimetric method. The test should be monotonous, the calibration should be done with the help II.2.1) Lot No: 16 NUTS code: 00 II.1.4) Short description Diagnostic test for quantitative determination of (1> 3) -beta-D-GLUCAN in serum or plasma by kinetic turbidimetric method. The test should be monotonous, the calibration should be done with the help of a QR scanner. Reagents should be ready for use. LAL (Limulus Amebocyte Lysate) based principle. The test time should be max. 90min. Measurement range: 6-600 pg / ml. Cut-off value: 11pg / ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Microimmunofluorescence test for the detection of specific IgM, IgA, and IgG antibodies to Chlamydia trachomatis; microscopic glass with applied antigens (LPS) of specifics or serotypes of purified el II.2.1) Lot No: 17 NUTS code: 00 II.1.4) Short description Microimmunofluorescence test for the detection of specific IgM, IgA, and IgG antibodies to Chlamydia trachomatis; microscopic glass with applied antigens (LPS) of specifics or serotypes of purified elemental bodies of Chlamydia trachomatis; semi-quantitative test for determination of titers of IgM, IgA and IgG antibodies; with controls (positive and negative human serum specifically for IgG, IgM, and IgA) and antihuman immunoglobulins conjugated with fluorescein (FITC reagent) II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Group: 142. TESTS FOR IMMUNOFLUORESCENTION (PNEUMOSLAGE) (The Lot is not divisible) II.2.1) Lot No: 18 NUTS code: 00 II.1.4) Short description Group: 142. TESTS FOR IMMUNOFLUORESCENTION (PNEUMOSLAGE) (Lot is not divisible): — indirect immunofluorescence test for respiratory pathogens causing atypical pneumonia; slides with applied antigens on 9 different microorganisms (bacteria Legionella pneumophila, Mycoplasma pneumoniae, Coxiella burnetii, Chlamydophila pneumoniae and viruses Adenovirus, RSV, Influenza A, Influenza B, Parainfluenza 1, 2 and 3) for IgG — indirect immunofluorescence test for respiratory pathogens causing atypical pneumonia; slides with applied antigens to 9 different microorganisms (bacteria Legionella pneumophila, Mycoplasma pneumoniae, Coxiella burnetii, Chlamydophila pneumoniae and viruses Adenovirus, RSV, Influenza A, Influenza B, Parainfluenza 1, 2 and 3) for IgM II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella O4; with a minimum volume of 2 ml II.2.1) Lot No: 19 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella O4; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella O9; with a minimum volume of 2 ml II.2.1) Lot No: 20 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella O9; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella Hg, m, with a minimum volume of 2 ml II.2.1) Lot No: 21 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella Hg, m, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella Hm; with a minimum volume of 2 ml II.2.1) Lot No: 22 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella Hm; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella flexneri (types: I, II, III, IV, V, VI), with a minimum volume of 2 ml II.2.1) Lot No: 23 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella flexneri (types: I, II, III, IV, V, VI), with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Antiserum for Yersinia enterocolitica O3, with a minimum volume of 2 ml II.2.1) Lot No: 24 NUTS code: 00 II.1.4) Short description Antiserum for Yersinia enterocolitica O3, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Antiserum for Yersinia enterocolitica O9, with a minimum volume of 2 ml II.2.1) Lot No: 25 NUTS code: 00 II.1.4) Short description Antiserum for Yersinia enterocolitica O9, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Salmonella O-groups from A to S, with a minimum volume of 2 ml II.2.1) Lot No: 26 NUTS code: 00 II.1.4) Short description Polyvalent serum for Salmonella O-groups from A to S, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Salmonella phase 1 and 2 (from a to z29), with a minimum volume of 2 ml II.2.1) Lot No: 27 NUTS code: 00 II.1.4) Short description Polyvalent serum for Salmonella phase 1 and 2 (from a to z29), with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Salmonella stage 2 (from H to l), with a minimum volume of 2 ml II.2.1) Lot No: 28 NUTS code: 00 II.1.4) Short description Polyvalent serum for Salmonella stage 2 (from H to l), with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella dysenteriae types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml II.2.1) Lot No: 29 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella dysenteriae types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella dysenteriae types 8, 9, 10, 11, 12, with a minimum volume of 2 ml II.2.1) Lot No: 30 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella dysenteriae types 8, 9, 10, 11, 12, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella boydii types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml II.2.1) Lot No: 31 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella boydii types 1, 2, 3, 4, 5, 6, 7; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella boydii types 8, 9, 10, 11, with a minimum volume of 2 ml II.2.1) Lot No: 32 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella boydii types 8, 9, 10, 11, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella boydii types 12, 13, 14, 15, with a minimum volume of 2 ml II.2.1) Lot No: 33 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella boydii types 12, 13, 14, 15, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella boydii types 16, 17, 18, with a minimum volume of 2 ml II.2.1) Lot No: 34 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella boydii types 16, 17, 18, with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella H e, h; with a minimum volume of 2 ml II.2.1) Lot No: 35 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella H e, h; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella H G; with a minimum volume of 2 ml II.2.1) Lot No: 36 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella H G; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella H 2; with a minimum volume of 2 ml II.2.1) Lot No: 37 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella H 2; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Antiserum for Salmonella H 5; with a minimum volume of 2 ml II.2.1) Lot No: 38 NUTS code: 00 II.1.4) Short description Antiserum for Salmonella H 5; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella H g, p; with a minimum volume of 2 ml II.2.1) Lot No: 39 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella H g, p; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Anti-serum for Salmonella H p; with a minimum volume of 2 ml II.2.1) Lot No: 40 NUTS code: 00 II.1.4) Short description Anti-serum for Salmonella H p; with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Polyvalent serum for Shigella sonnei D (Phase I, Phase II); with a minimum volume of 2 ml II.2.1) Lot No: 41 NUTS code: 00 II.1.4) Short description Polyvalent serum for Shigella sonnei D (Phase I, Phase II); with a minimum volume of 2 ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Immunochromatographic test for proving Rotavirus / Adenovirus antigens in feces, with low positive control, with a minimum sensitivity of 90 % and a minimum specificity of 99 % II.2.1) Lot No: 42 NUTS code: 00 II.1.4) Short description Immunochromatographic test for proving Rotavirus / Adenovirus antigens in feces, with low positive control, with a minimum sensitivity of 90 % and a minimum specificity of 99 % II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Immunochromatographic test for detection of Cl difficile glutamate dehydrogenase in feces, with positive control included, with 99 % sensitivity, 99 % specificity and analytical sensitivity: 0.39 ng / m II.2.1) Lot No: 43 NUTS code: 00 II.1.4) Short description Immunochromatographic test for detection of Cl difficile glutamate dehydrogenase in feces, with positive control included, with 99 % sensitivity, 99 % specificity and analytical sensitivity: 0.39 ng / ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Helicobacter pylori antigen immunogenomatographic test in faeces, with positive control included, with a minimum sensitivity of 99 %, a specificity of 99 % and a detection limit of 10 ng / ml II.2.1) Lot No: 44 NUTS code: 00 II.1.4) Short description Helicobacter pylori antigen immunogenomatographic test in faeces, with positive control included, with a minimum sensitivity of 99 %, a specificity of 99 % and a detection limit of 10 ng / ml II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Immunochromatographic test for Rota virus in feces, with positive control included, with a minimum specificity of 99 % and a sensitivity of 99 % II.2.1) Lot No: 45 NUTS code: 00 II.1.4) Short description Immunochromatographic test for Rota virus in feces, with positive control included, with a minimum specificity of 99 % and a sensitivity of 99 % II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Immunochromatographic test for detection of toxins A and B separately, in Clostridium difficile directly from feces, with positive control included, with a minimum specificity of 99 % and a sensitivit II.2.1) Lot No: 46 NUTS code: 00 II.1.4) Short description Immunochromatographic test for detection of toxins A and B separately, in Clostridium difficile directly from feces, with positive control included, with a minimum specificity of 99 % and a sensitivity of 99 % II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Indirect immunofluorescence (IIF) for Leshmania donovani (IgG, IgM); slides with applied antigens, with included positive and negative control II.2.1) Lot No: 47 NUTS code: 00 II.1.4) Short description Indirect immunofluorescence (IIF) for Leshmania donovani (IgG, IgM); slides with applied antigens, with included positive and negative control II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no Direct immunofluorescence (DIF) for Chlamydia trachomatis; slides with autumn protein (MOMP) antigen of C trachomatis, with positive control included II.2.1) Lot No: 48 NUTS code: 00 II.1.4) Short description Direct immunofluorescence (DIF) for Chlamydia trachomatis; slides with autumn protein (MOMP) antigen of C trachomatis, with positive control included II.2.5) Award criteria: Cost/Price II.02.07) Duration in months 12 II.2.7.5) This contract is subject to renewal: no II.2.10) Variants will be accepted: no The procurement is related to a project and/or programme financed by European Union funds): no III.1.1) List and brief description of conditions — statement by the economic operator that it has not been sentenced, in the last 5 years, with effective Court decision for participation in criminal organisation, corruption, fraud or money laundering; — certificate that it is not subject to bankruptcy procedure issued by competent authority, — certificate that it is not subject to liquidation procedure issued by competent authority, — certificate for paid taxes, contributions and other public dues by the competent authority in the country where that economic operator is established; — certificate from the legal entities penal registry that it is not being imposed a side sanction, — prohibition to participate in public competitions, public procurement contract award and public, — private partnership contract award procedures, — certificate from the legal entities penal registry that it is not being imposed a side sanction, — temporary or permanent prohibition to perform certain professional activity, — certificate that it is not being sanctioned for misdemeanor with an effective court decision, resulting in prohibition for pursuing professional activity or duty, i.e. temporary prohibition for performing certain business activity. Ability of the economic operator to perform business activity: — document for registered business activity, — certificate for wholesale of medical devices in accordance with the Law on medicines and medical devices. III.2.2) Contract performance conditions Contract performance guarantee: Bank guarantee of 10 % IV.1.1) Type of procedure: Open IV.2.1) Time limit for receipt of tenders or requests to participate IV.2.2) Date 2020-08-06 IV.2.2) Local time 10:00 IV.2.7) Conditions for opening of tenders IV.2.7) Date 2020-08-06 IV.2.7) Local time 10:00 IV.02.07) Place Electronically, ESJN (https://www.e-nabavki.gov.mk/); Ss. Cyril and Methodius University, Faculty of Medicine — Skopje, 50 Divizija No 6, 1000 Skopje, REPUBLIC of MACEDONIA. Year 2021. Additional Information: https://www.e-nabavki.gov.mk/PublicAccess/home.aspx#/dossie/0da80140-13da-40f3-b6da-67ef96a26b5b/1 Review body: Date of dispatch of this notice : 2020-07-07 |
| CPV Codes |
| 33694000; Diagnostic agents; |
Sign-up now to receive weekly OJEU reports for the UK, your sector and/or elsewhere in the EU. We also report on the procurement of EC Institutions. |
|